Orelabrutinib,Rituximab and Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma

Condition:   Primary Central Nervous System Lymphoma Interventions:   Drug: Orelabrutinib;   Drug: Rituximab;   Drug: Methotrexate Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials